The city of Anchorage, Alaska, currently has 1 active clinical trials seeking participants for Arthritis research studies.
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients
Recruiting
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
05/31/2024
Locations: Arthrosi Investigative Site (139), Anchorage, Alaska
Conditions: Gout, Arthritis, Gouty, Hyperuricemia, Gout Chronic